These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18516776)

  • 1. [Is there a drug therapy for age-related macular degeneration?--current status and new therapeutic approaches].
    Augustin AJ; Offermann I
    Klin Monbl Augenheilkd; 2008 Jun; 225(6):555-63. PubMed ID: 18516776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approaches toward combining photodynamic therapy with pharmaceuticals that alter vascular microenvironment.
    Busch T
    Retina; 2009 Jun; 29(6 Suppl):S36-8. PubMed ID: 19553798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chronic central serous chorioretinopathy (cCSC): differential diagnosis to choroidal neovascularisation (CNV) secondary to age-related macular degeneration (AMD)].
    Inhoffen W; Ziemssen F; Bartz-Schmidt KU
    Klin Monbl Augenheilkd; 2012 Sep; 229(9):889-96. PubMed ID: 22930236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
    Goff MJ; Johnson RN; McDonald HR; Ai E; Jumper JM; Fu A
    Retina; 2007; 27(4):432-8. PubMed ID: 17420694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of combination therapies for neovascular age-related macular degeneration.
    Couch SM; Bakri SJ
    Semin Ophthalmol; 2011 May; 26(3):114-20. PubMed ID: 21609223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiangiogenic approaches to age-related macular degeneration today.
    Bressler NM
    Ophthalmology; 2009 Oct; 116(10 Suppl):S15-23. PubMed ID: 19800535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidance for the treatment of neovascular age-related macular degeneration.
    Schmidt-Erfurth UM; Richard G; Augustin A; Aylward WG; Bandello F; Corcòstegui B; Cunha-Vaz J; Gaudric A; Leys A; Schlingemann RO;
    Acta Ophthalmol Scand; 2007 Aug; 85(5):486-94. PubMed ID: 17655610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration.
    Ahmadieh H; Taei R; Soheilian M; Riazi-Esfahani M; Karkhaneh R; Lashay A; Azarmina M; Dehghan MH; Moradian S
    BMC Ophthalmol; 2007 Jun; 7():10. PubMed ID: 17555600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMD--the retinal disease with an unprecised etiopathogenesis: in search of effective therapeutics.
    Nowak JZ
    Acta Pol Pharm; 2014; 71(6):900-16. PubMed ID: 25745762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wet age-related macular degeneration.
    Kulkarni AD; Kuppermann BD
    Adv Drug Deliv Rev; 2005 Dec; 57(14):1994-2009. PubMed ID: 16309781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photodynamic therapy with intravitreal application of triamcinolone acetonide in age-related macular degeneration: functional results in 54 patients.
    Frimpong-Boateng A; Bunse A; Rüfer F; Roider J
    Acta Ophthalmol; 2009 Mar; 87(2):183-7. PubMed ID: 18547278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-VEGF agents for age-related macular degeneration.
    Ozkiris A
    Expert Opin Ther Pat; 2010 Jan; 20(1):103-18. PubMed ID: 20021287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bevacizumab and neovascular age related macular degeneration: pathogenesis and treatment.
    El-Mollayess GM; Noureddine BN; Bashshur ZF
    Semin Ophthalmol; 2011 May; 26(3):69-76. PubMed ID: 21609219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined therapy in exudative age-related macular degeneration.
    Figurska M; Wierzbowska J; Robaszkiewicz J
    Klin Oczna; 2010; 112(7-9):223-9. PubMed ID: 21117365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal bevacizumab combined with photodynamic therapy for the treatment of occult choroidal neovascularization associated with serous pigment epithelium detachment in age-related macular degeneration.
    Ladas ID; Kotsolis AI; Papakostas TD; Rouvas AA; Karagiannis DA; Vergados I
    Retina; 2007 Sep; 27(7):891-6. PubMed ID: 17891013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Age-related macular degeneration (AMD): etiopathogenesis and therapeutic strategies].
    Nowak JZ; Bienias W
    Postepy Hig Med Dosw (Online); 2007; 61():83-94. PubMed ID: 17369776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathogenesis of choroidal neovascularization. Old concepts, new questions].
    Fauser S; Engelmann K; Krohne TU; Lappas A; Kirchhof B; Joussen AM
    Ophthalmologe; 2003 Apr; 100(4):300-5. PubMed ID: 12682762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration.
    Ferrara N; Damico L; Shams N; Lowman H; Kim R
    Retina; 2006 Oct; 26(8):859-70. PubMed ID: 17031284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined intravitreal pharmacosurgery in patients with occult choroidal neovascularization secondary to wet age-related macular degeneration.
    Koss MJ; Scholtz S; Haeussler-Sinangin Y; Singh P; Koch FH
    Ophthalmologica; 2010; 224(2):72-8. PubMed ID: 19707030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-angiogenic therapy of exudative age-related macular degeneration: current progress and emerging concepts.
    Noël A; Jost M; Lambert V; Lecomte J; Rakic JM
    Trends Mol Med; 2007 Aug; 13(8):345-52. PubMed ID: 17644433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.